|
1
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maddams J, Utley M and Moller H:
Projections of cancer prevalence in the United Kingdom, 2010–2040.
Br J Cancer. 107:1195–1202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang L, Wilson SE, Stewart DB and
Hollenbeak CS: Marital status and colon cancer outcomes in us
Surveillance, epidemiology and end results registries: Does
marriage affect cancer survival by gender and stage? Cancer
Epidemiol. 35:417–422. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chiu BC, Ji BT, Dai Q, Gridley G,
McLaughlin JK, Gao YT, Fraumeni JF Jr and Chow WH: Dietary factors
and risk of colon cancer in Shanghai, China. Cancer Epidemiol
Biomarkers Prev. 12:201–208. 2003.PubMed/NCBI
|
|
5
|
Hou L, Ji BT, Blair A, Dai Q, Gao YT and
Chow WH: Commuting physical activity and risk of colon cancer in
Shanghai, China. Am J Epidemiol. 160:860–867. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Benson AB III, Bekaii-Saab T, Chan E, Chen
YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fenton
MJ, et al: Metastatic colon cancer, version 3.2013: Featured
updates to the NCCN guidelines. J Natl Compr Canc Netw. 11:141–152.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Terzic J, Grivennikov S, Karin E and Karin
M: Inflammation and colon cancer. Gastroenterology.
138:2101–2114.e5. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rei M, Goncalves-Sousa N, Lanca T,
Thompson RG, Mensurado S, Balkwill FR, Kulbe H, Pennington DJ and
Silva-Santos B: Murine CD27(−) Vgamma6(+) gammadelta T cells
producing IL-17A promote ovarian cancer growth via mobilization of
protumor small peritoneal macrophages. Proc Natl Acad Sci USA.
111:E3562–E3570. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ma S, Cheng Q, Cai Y, Gong H, Wu Y, Yu X,
Shi L, Wu D, Dong C and Liu H: IL-17A produced by gammadelta T
cells promotes tumor growth in hepatocellular carcinoma. Cancer
Res. 74:1969–1982. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Srivastava A, Nikamo P, Lohcharoenkal W,
Li D, Meisgen F, Xu Landén N, Ståhle M, Pivarcsi A and Sonkoly E:
MicroRNA-146a suppresses IL-17-mediated skin inflammation and is
genetically associated with psoriasis. J Allergy Clin Immunol.
139:550–561. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yanagisawa N, Maeda K, Ajisawa A, Imamura
A, Suganuma A, Ando M, Takayama N and Okuno Y: Reduced immune
response to influenza A (H1N1) 2009 monovalent vaccine in
HIV-infected Japanese subjects. Vaccine. 29:5694–5698. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liao Y, Cheng S, Xiang J and Luo C: lncRNA
CCHE1 increased proliferation, metastasis and invasion of non-small
lung cancer cells and predicted poor survival in non-small lung
cancer patients. Eur Rev Med Pharmacol Sci. 22:1686–1692.
2018.PubMed/NCBI
|
|
13
|
Xu G, Zhang Y, Li N, Zhang JB and Xu R:
LncRNA CCHE1 in the proliferation and apoptosis of gastric cancer
cells. Eur Rev Med Pharmacol Sci. 22:2631–2637. 2018.PubMed/NCBI
|
|
14
|
Yang M, Zhai X, Xia B, Wang Y and Lou G:
Long noncoding RNA CCHE1 promotes cervical cancer cell
proliferation via upregulating PCNA. Tumour Biol. 36:7615–7622.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peng W and Fan H: Long noncoding RNA CCHE1
indicates a poor prognosis of hepatocellular carcinoma and promotes
carcinogenesis via activation of the ERK/MAPK pathway. Biomed
Pharmacother. 83:450–455. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gaballah HH, Gaber RA, Elrashidy MA,
Elshahat DA, Hablus MA and Ebeid AM: Expression of long non-coding
RNA CCHE1 in colorectal carcinoma: Correlations with
clinicopathological features and ERK/COX-2 pathway. Mol Biol Rep.
46:657–667. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mace AG, Pai RK, Stocchi L and Kalady MF:
American joint committee on cancer and college of american
pathologists regression grade: A new prognostic factor in rectal
cancer. Dis Colon Rectum. 58:32–44. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xue Y, Ma G, Gu D, Zhu L, Hua Q, Du M, Chu
H, Tong N, Chen J, Zhang Z and Wang M: Genome-wide analysis of long
noncoding RNA signature in human colorectal cancer. Gene.
556:227–234. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shi J, Li X, Zhang F, Zhang C, Guan Q, Cao
X, Zhu W, Zhang X, Cheng Y, Ou K, et al: Circulating lncRNAs
associated with occurrence of colorectal cancer progression. Am J
Cancer Res. 5:2258–2265. 2015.PubMed/NCBI
|
|
21
|
Wang L, Yi T, Kortylewski M, Pardoll DM,
Zeng D and Yu H: IL-17 can promote tumor growth through an
IL-6-Stat3 signaling pathway. J Exp Med. 206:1457–1464. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He D, Li H, Yusuf N, Elmets CA, Li J,
Mountz JD and Xu H: IL-17 promotes tumor development through the
induction of tumor promoting microenvironments at tumor sites and
myeloid-derived suppressor cells. J Immunol. 184:2281–2288. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang B, Kang H, Fung A, Zhao H, Wang T and
Ma D: The role of interleukin 17 in tumour proliferation,
angiogenesis, and metastasis. Mediators Inflamm. 2014:6237592014.
View Article : Google Scholar : PubMed/NCBI
|
